Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Studies on the Site(s) of Blockade by Actinomycin-D of Estrogen-Induced LH Release

Studies on the Site(s) of Blockade by Actinomycin-D of Estrogen-Induced LH Release Ovariectomized rats were injected with estradiol benzoate (EB) on day 1. The rats received propylene glycol alone (control) or with Actinomycin-D (Act-D) at 08.00 h, followed by EB at 12.00 h on day 3. Plasma LH levels were markedly elevated at 18.00 h on days 3 and 4 in control rats; Act-D treatment failed to modify the surge of LH on day 3, but abolished it on day 4. The site of Act-D’s blockade of estrogen-induced LH release was investigated. Act-D treatment suppressed serum levels of LRF while it failed to modify either hypothalamic LRF content or noon levels of pituitary and serum LH on day 4. Act-D treatment consistently reduced the weight and the ribonucleic acid (RNA) content of the pituitary; a similar effect on RNA in the medial basal hypothalamus was not detected on day 4. On the other hand, electrochemical stimulation of the medial preoptic area of Act-D-treated rats on day 4 raised plasma LH significantly. However, the elevations at 45 min after stimulation were less in Act-D-treated than in control rats. Similarly, a significantly smaller response of LH release was observed at 15 min following intravenous injections of LRF in Act-D rats than in controls. These studies suggest that Act-D-sensitive steps exist at more than one site on the preopticotuberal pituitary axis involved in the stimulatory feedback action of estrogen on LH release. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neuroendocrinology Karger

Studies on the Site(s) of Blockade by Actinomycin-D of Estrogen-Induced LH Release

Kalra, S.P.
Neuroendocrinology , Volume 18 (4): 12 – Jan 1, 1975
Download PDF
12 pages

Loading next page...
 
/lp/karger/studies-on-the-site-s-of-blockade-by-actinomycin-d-of-estrogen-induced-uYhtHmnaHg

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Karger
Copyright
© 1975 S. Karger AG, Basel
ISSN
0028-3835
eISSN
1423-0194
DOI
10.1159/000122414
Publisher site
See Article on Publisher Site

Abstract

Ovariectomized rats were injected with estradiol benzoate (EB) on day 1. The rats received propylene glycol alone (control) or with Actinomycin-D (Act-D) at 08.00 h, followed by EB at 12.00 h on day 3. Plasma LH levels were markedly elevated at 18.00 h on days 3 and 4 in control rats; Act-D treatment failed to modify the surge of LH on day 3, but abolished it on day 4. The site of Act-D’s blockade of estrogen-induced LH release was investigated. Act-D treatment suppressed serum levels of LRF while it failed to modify either hypothalamic LRF content or noon levels of pituitary and serum LH on day 4. Act-D treatment consistently reduced the weight and the ribonucleic acid (RNA) content of the pituitary; a similar effect on RNA in the medial basal hypothalamus was not detected on day 4. On the other hand, electrochemical stimulation of the medial preoptic area of Act-D-treated rats on day 4 raised plasma LH significantly. However, the elevations at 45 min after stimulation were less in Act-D-treated than in control rats. Similarly, a significantly smaller response of LH release was observed at 15 min following intravenous injections of LRF in Act-D rats than in controls. These studies suggest that Act-D-sensitive steps exist at more than one site on the preopticotuberal pituitary axis involved in the stimulatory feedback action of estrogen on LH release.

Journal

Neuroendocrinology – Karger

Published: Jan 1, 1975

Keywords: Estrogen; LH surge; Actinomycin-D; Site(s)

There are no references for this article.